Literature DB >> 26010642

Mortality and ratio of blood products used in patients with severe trauma--reply.

John B Holcomb1, Erin E Fox1, Charles E Wade1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26010642      PMCID： PMC4518852          DOI： 10.1001/jama.2015.4427

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  Prevalence of survivor bias in observational studies on fresh frozen plasma:erythrocyte ratios in trauma requiring massive transfusion.

Authors:  Anthony M-H Ho; Peter W Dion; Janice H H Yeung; John B Holcomb; Lester A H Critchley; Calvin S H Ng; Manoj K Karmakar; Chi W Cheung; Timothy H Rainer
Journal:  Anesthesiology       Date:  2012-03       Impact factor: 7.892

2.  How I treat patients with massive hemorrhage.

Authors:  Pär I Johansson; Jakob Stensballe; Roberto Oliveri; Charles E Wade; Sisse R Ostrowski; John B Holcomb
Journal:  Blood       Date:  2014-10-07       Impact factor: 22.113

3.  Collider bias in trauma comparative effectiveness research: the stratification blues for systematic reviews.

Authors:  Deborah J Del Junco; Eileen M Bulger; Erin E Fox; John B Holcomb; Karen J Brasel; David B Hoyt; James J Grady; Sarah Duran; Patricia Klotz; Michael A Dubick; Charles E Wade
Journal:  Injury       Date:  2015-01-31       Impact factor: 2.586

4.  Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients.

Authors:  John B Holcomb; Kristin M Minei; Michelle L Scerbo; Zayde A Radwan; Charles E Wade; Rosemary A Kozar; Brijesh S Gill; Rondel Albarado; Michelle K McNutt; Saleem Khan; Phillip R Adams; James J McCarthy; Bryan A Cotton
Journal:  Ann Surg       Date:  2012-09       Impact factor: 12.969

5.  The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks.

Authors:  John B Holcomb; Deborah J del Junco; Erin E Fox; Charles E Wade; Mitchell J Cohen; Martin A Schreiber; Louis H Alarcon; Yu Bai; Karen J Brasel; Eileen M Bulger; Bryan A Cotton; Nena Matijevic; Peter Muskat; John G Myers; Herb A Phelan; Christopher E White; Jiajie Zhang; Mohammad H Rahbar
Journal:  JAMA Surg       Date:  2013-02       Impact factor: 14.766
  5 in total
  3 in total

1.  Mesenchymal stem cell-derived extracellular vesicles attenuate pulmonary vascular permeability and lung injury induced by hemorrhagic shock and trauma.

Authors:  Daniel R Potter; Byron Y Miyazawa; Stuart L Gibb; Xutao Deng; Padma P Togaratti; Roxanne H Croze; Amit K Srivastava; Alpa Trivedi; Michael Matthay; John B Holcomb; Martin A Schreiber; Shibani Pati
Journal:  J Trauma Acute Care Surg       Date:  2018-02       Impact factor: 3.313

Review 2.  [Hemoglobin-oriented and coagulation factor-based algorithm : Effect on transfusion needs and standardized mortality rate in massively transfused trauma patients].

Authors:  P Hilbert-Carius; G Hofmann; R Stuttmann
Journal:  Anaesthesist       Date:  2015-10-09       Impact factor: 1.041

3.  Treating the endotheliopathy of SARS-CoV-2 infection with plasma: Lessons learned from optimized trauma resuscitation with blood products.

Authors:  Shibani Pati; Erin Fennern; John B Holcomb; Mark Barry; Alpa Trivedi; Andrew P Cap; Matthew J Martin; Charles Wade; Rosemary Kozar; Jessica C Cardenas; Joseph F Rappold; Renee Spiegel; Martin A Schreiber
Journal:  Transfusion       Date:  2021-07       Impact factor: 3.157
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.